Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 1
Submit an article Journal homepage
358
Views
7
CrossRef citations to date
0
Altmetric
Letters to the Editor

Effect of antibiotic use on outcomes in patients with Hodgkin lymphoma treated with immune checkpoint inhibitors

Steven R. Hwanga Department of Medicine, Mayo Clinic, Rochester, MN, USAORCID Iconhttps://orcid.org/0000-0002-6536-1291View further author information
ORCID Icon,
Alexandra Higginsb Division of Hematology, Mayo Clinic, Rochester, MN, USAORCID Iconhttps://orcid.org/0000-0001-6626-0700View further author information
ORCID Icon,
Natalia E. Castillo Almeidac Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USAORCID Iconhttps://orcid.org/0000-0002-9904-7137View further author information
ORCID Icon,
Betsy LaPlantd Department of Biostatistics, Mayo Clinic, Rochester, MN, USAView further author information
,
Matthew J. Maurerd Department of Biostatistics, Mayo Clinic, Rochester, MN, USAORCID Iconhttps://orcid.org/0000-0002-1867-0526View further author information
ORCID Icon,
Stephen M. Ansellb Division of Hematology, Mayo Clinic, Rochester, MN, USAView further author information
,
Thomas E. Witzigb Division of Hematology, Mayo Clinic, Rochester, MN, USAORCID Iconhttps://orcid.org/0000-0002-4215-6500View further author information
ORCID Icon,
Gita Thanarajasingamb Division of Hematology, Mayo Clinic, Rochester, MN, USAORCID Iconhttps://orcid.org/0000-0003-2144-5415View further author information
ORCID Icon &
N. Nora Bennanib Division of Hematology, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8358-5953View further author information
ORCID Icon show all
Pages 247-251 | Received 13 Jul 2020, Accepted 13 Sep 2020, Published online: 06 Oct 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

NNB serves on the advisory board for Acrotech, Verastem, Seattle Genetics, and Purdue Pharma. SMA receives research funding from BMS, Seattle Genetics, Affirmed, Regeneron, Trillium, AI Therapeutics, and ADC Therapeutics. The other authors report no conflicts of interest.

Author contributions

NNB, SRH, and AH designed the study. NNB supervised the project. SRH and AH collected all study data and participated in data analysis and interpretation. SRH drafted the initial manuscript. BL and MJM assisted in data analysis and statistic support. All authors participated in revising the manuscript prior to submission.

Acknowledgements

An earlier version of these data was presented as a virtual poster at the 2020 annual ASCO meeting.

Additional information

Funding

This study was supported in part by the Mayo Clinic Lymphoma Database, the University of Iowa/Mayo Clinic Lymphoma SPORE CA97274, and the Predolin Foundation.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.